We are live on ! Find out more
ANGO icon

AngioDynamics

150 hedge funds and large institutions have $366M invested in AngioDynamics in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $491K | Put options by funds: $222K

10% more capital invested

Capital invested by funds: $332M → $366M (+$34M)

3.55% more ownership

Funds ownership: 87.14%90.69% (+3.6%)

4% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 53

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3% less funds holding

Funds holding: 154150 (-4)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
150
Holders Change
-4
Holders Change %
-2.6%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
55
Reduced
53
Closed
22
Calls
$491K
Puts
$222K
Net Calls
+$269K
Net Calls Change
+$428K
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
51
Squarepoint
New York
$850K +$185K +18,879 +28%
SCM
52
Stonepine Capital Management
Oregon
$765K +$755K +77,141 New
SG
53
StoneX Group
New York
$738K -$2.38K -243 -0.3%
Barclays
54
Barclays
United Kingdom
$733K +$342K +34,966 +90%
JP Morgan Chase
55
JP Morgan Chase
New York
$718K -$2.48M -253,681 -78%
Franklin Resources
56
Franklin Resources
California
$707K +$969 +99 +0.1%
Mitsubishi UFJ Asset Management
57
Mitsubishi UFJ Asset Management
Japan
$694K -$681K -69,550 -50%
AQR Capital Management
58
AQR Capital Management
Connecticut
$686K -$266K -27,150 -28%
LCM
59
Legato Capital Management
California
$682K +$153K +15,632 +29%
Jane Street
60
Jane Street
New York
$678K +$211K +21,526 +46%
Envestnet Asset Management
61
Envestnet Asset Management
Illinois
$677K -$1.69M -172,625 -72%
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$648K -$1.62M -165,564 -72%
WPC
63
White Pine Capital
Minnesota
$646K +$9.22K +942 +1%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$608K +$24.6K +2,510 +4%
AllianceBernstein
65
AllianceBernstein
Tennessee
$557K +$65.6K +6,700 +14%
MNBTD
66
Moody National Bank Trust Division
Texas
$555K
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$542K
SO
68
STRS Ohio
Ohio
$495K -$47K -4,800 -9%
Two Sigma Investments
69
Two Sigma Investments
New York
$465K -$788K -80,536 -63%
EI
70
EAM Investors
California
$446K -$2.84M -290,550 -87%
FP
71
Factorial Partners
New York
$427K -$343K -35,000 -45%
T. Rowe Price Associates
72
T. Rowe Price Associates
Maryland
$404K +$22.1K +2,253 +6%
EGM
73
Engineers Gate Manager
New York
$392K +$387K +39,491 New
Balyasny Asset Management
74
Balyasny Asset Management
Illinois
$389K -$590K -60,247 -61%
Janney Montgomery Scott
75
Janney Montgomery Scott
Pennsylvania
$345K

ANGO Hedge Fund Activity: Q2 2025 in Review

150 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q2 2025, worth a combined $366M — up 10% from $332M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ANGO and 19 opened new positions — a net loss of 3 holders — while 53 trimmed existing stakes and 55 added.

The largest buyer was Divisadero Street Capital Management, adding an estimated $23.8M. The largest seller was Armistice Capital, cutting an estimated $5.54M.

  • 150 institutional investors held AngioDynamics (ANGO) as of Q2 2025, down from 154 in Q1 2025.
  • Funds reported $366M of AngioDynamics stock for Q2 2025, up 10% quarter-over-quarter.
  • 19 funds opened new AngioDynamics positions in Q2 2025 and 22 closed out, a net change of -3 holders.
  • The largest AngioDynamics buyer in Q2 2025 was Divisadero Street Capital Management, an estimated $23.8M added.
  • The largest AngioDynamics seller in Q2 2025 was Armistice Capital, an estimated $5.54M sold.

Based on aggregated 13F filings for Q2 2025.